ABBV
Price
$186.91
Change
-$14.73 (-7.31%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
322.43B
20 days until earnings call
GILD
Price
$107.26
Change
-$5.13 (-4.56%)
Updated
Apr 4, 04:59 PM (EDT)
Capitalization
90.79B
19 days until earnings call
Ad is loading...

ABBV vs GILD

Header iconABBV vs GILD Comparison
Open Charts ABBV vs GILDBanner chart's image
ABBVIE
Price$186.91
Change-$14.73 (-7.31%)
Volume$127.15K
Capitalization322.43B
Gilead Sciences
Price$107.26
Change-$5.13 (-4.56%)
Volume$270.18K
Capitalization90.79B
ABBV vs GILD Comparison Chart
Loading...
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABBV vs. GILD commentary
Apr 05, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABBV is a Hold and GILD is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 05, 2025
Stock price -- (ABBV: $201.64 vs. GILD: $112.39)
Brand notoriety: ABBV and GILD are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: ABBV: 115% vs. GILD: 109%
Market capitalization -- ABBV: $322.43B vs. GILD: $90.79B
ABBV [@Pharmaceuticals: Major] is valued at $322.43B. GILD’s [@Pharmaceuticals: Major] market capitalization is $90.79B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABBV’s FA Score shows that 4 FA rating(s) are green whileGILD’s FA Score has 2 green FA rating(s).

  • ABBV’s FA Score: 4 green, 1 red.
  • GILD’s FA Score: 2 green, 3 red.
According to our system of comparison, both ABBV and GILD are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABBV’s TA Score shows that 4 TA indicator(s) are bullish while GILD’s TA Score has 4 bullish TA indicator(s).

  • ABBV’s TA Score: 4 bullish, 4 bearish.
  • GILD’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, ABBV is a better buy in the short-term than GILD.

Price Growth

ABBV (@Pharmaceuticals: Major) experienced а -0.53% price change this week, while GILD (@Pharmaceuticals: Major) price change was +1.11% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -3.78%. For the same industry, the average monthly price growth was -5.97%, and the average quarterly price growth was -9.78%.

Reported Earning Dates

ABBV is expected to report earnings on Apr 25, 2025.

GILD is expected to report earnings on Apr 24, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-3.78% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABBV($322B) has a higher market cap than GILD($90.8B). ABBV has higher P/E ratio than GILD: ABBV (66.46) vs GILD (16.20). GILD YTD gains are higher at: 22.528 vs. ABBV (14.542). ABBV has higher annual earnings (EBITDA): 17.2B vs. GILD (10.5B). ABBV has more cash in the bank: 12.8B vs. GILD (7.26B). GILD has less debt than ABBV: GILD (25B) vs ABBV (59.4B). ABBV has higher revenues than GILD: ABBV (54.3B) vs GILD (27.1B).
ABBVGILDABBV / GILD
Capitalization322B90.8B355%
EBITDA17.2B10.5B164%
Gain YTD14.54222.52865%
P/E Ratio66.4616.20410%
Revenue54.3B27.1B200%
Total Cash12.8B7.26B176%
Total Debt59.4B25B238%
FUNDAMENTALS RATINGS
ABBV vs GILD: Fundamental Ratings
ABBV
GILD
OUTLOOK RATING
1..100
6177
VALUATION
overvalued / fair valued / undervalued
1..100
77
Overvalued
34
Fair valued
PROFIT vs RISK RATING
1..100
513
SMR RATING
1..100
1788
PRICE GROWTH RATING
1..100
2639
P/E GROWTH RATING
1..100
201
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GILD's Valuation (34) in the Biotechnology industry is somewhat better than the same rating for ABBV (77) in the Pharmaceuticals Major industry. This means that GILD’s stock grew somewhat faster than ABBV’s over the last 12 months.

ABBV's Profit vs Risk Rating (5) in the Pharmaceuticals Major industry is in the same range as GILD (13) in the Biotechnology industry. This means that ABBV’s stock grew similarly to GILD’s over the last 12 months.

ABBV's SMR Rating (17) in the Pharmaceuticals Major industry is significantly better than the same rating for GILD (88) in the Biotechnology industry. This means that ABBV’s stock grew significantly faster than GILD’s over the last 12 months.

ABBV's Price Growth Rating (26) in the Pharmaceuticals Major industry is in the same range as GILD (39) in the Biotechnology industry. This means that ABBV’s stock grew similarly to GILD’s over the last 12 months.

GILD's P/E Growth Rating (1) in the Biotechnology industry is in the same range as ABBV (20) in the Pharmaceuticals Major industry. This means that GILD’s stock grew similarly to ABBV’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ABBVGILD
RSI
ODDS (%)
Bearish Trend 4 days ago
33%
Bearish Trend 4 days ago
57%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
51%
Bearish Trend 4 days ago
51%
Momentum
ODDS (%)
Bearish Trend 4 days ago
40%
Bullish Trend 4 days ago
51%
MACD
ODDS (%)
Bearish Trend 4 days ago
47%
Bearish Trend 4 days ago
46%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
60%
Bullish Trend 4 days ago
55%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
51%
Bearish Trend 4 days ago
48%
Advances
ODDS (%)
Bullish Trend 5 days ago
59%
Bullish Trend 5 days ago
59%
Declines
ODDS (%)
Bearish Trend 10 days ago
43%
Bearish Trend 16 days ago
48%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
54%
Bullish Trend 4 days ago
52%
Aroon
ODDS (%)
Bullish Trend 4 days ago
57%
Bullish Trend 4 days ago
58%
View a ticker or compare two or three
Ad is loading...
ABBV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X83102.830000617.109400
+0.75%
Bitcoin cryptocurrency
SPY536.70-27.82
-4.93%
SPDR® S&P 500® ETF Trust
TSLA267.28-15.48
-5.47%
Tesla
GME21.10-1.59
-7.01%
GameStop Corp
AAPL203.19-20.70
-9.25%
Apple

ABBV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABBV has been loosely correlated with JNJ. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if ABBV jumps, then JNJ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABBV
1D Price
Change %
ABBV100%
-1.73%
JNJ - ABBV
41%
Loosely correlated
+2.87%
AMGN - ABBV
35%
Loosely correlated
+1.36%
MRK - ABBV
35%
Loosely correlated
-0.24%
PFE - ABBV
34%
Loosely correlated
-1.66%
BMY - ABBV
34%
Loosely correlated
-2.99%
More

GILD and

Correlation & Price change

A.I.dvisor indicates that over the last year, GILD has been loosely correlated with JNJ. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if GILD jumps, then JNJ could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GILD
1D Price
Change %
GILD100%
+0.45%
JNJ - GILD
40%
Loosely correlated
+2.87%
BMY - GILD
36%
Loosely correlated
-2.99%
PFE - GILD
31%
Poorly correlated
-1.66%
ABBV - GILD
28%
Poorly correlated
-1.73%
GSK - GILD
27%
Poorly correlated
+3.64%
More